A new pill to treat advanced hormone sensitive prostate cancer that could benefit just over 40,000 people has been ...
Rucaparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapy [ID5100] Draft guidance Technology appraisal ...
12 SQ-HDM SLIT for treating allergic rhinitis and allergic asthma caused by house dust mites (review of TA834) [ID6280] Technology appraisal guidance 12 February 2025 Abaloparatide for treating ...
During the pre-election period, 22 May to 5 July 2024, restrictions imposed on public bodies meant NICE was prevented from publicising its work. We did still continue developing useful and useable ...
A digital technology that will help healthcare professionals provide a quicker diagnosis to people with attention deficit hyperactivity disorder (ADHD) can be used by the NHS, NICE has said in draft ...
Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...
Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...
Further information Decision makers have concluded that this technology will not progress as a potential technology appraisal (TA) or a highly specialised technology (HST) as is not a new active ...
Iodine (131I)–apamistamab for treating relapsed or refractory acute myeloid leukaemia before an allogeneic haematopoietic stem cell transplant [ID6355] Technology appraisal guidance TBC Ipatasertib ...
Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance. We also have resources to help local partnerships tackle their priorities. For advice specific to ...